Hans Lee, MD

Articles by Hans Lee, MD

Hans Lee, MD, Covers Outcomes, Treatments After Triple-Class Exposure in Myeloma

Hans Lee, MDMyeloma | December 19, 2023

Dr. Hans Lee met with Blood Cancers Today to discuss outcomes and treatments after triple-class exposure in multiple myeloma.

Hans Lee, MD, on the LINKER-MM1 Study of Linvoseltamab in Multiple Myeloma

Cecilia BrownMyeloma | September 5, 2023

The phase II study evaluated linvoseltamab, a bispecific antibody targeting BCMA and CD3, in relapsed or refractory MM.